Industry News
Melbourne firm develops JAK kinase inhibitor
A new JAK kinase inhibitor developed by Melbourne biotech Cytopia had far higher activity than blockbuster drug Glivec in tests on cells from a patient with chronic myeloid leukaemia, the company announced today. [ + ]
Axon teams with Affymetrix to develop gene scanning system
Drug discovery instrumentation company Axon Instruments is joining forces with genomics tools supplier Affymetrix to develop a new type of gene scanning system that could deliver a much-needed revenue boost to Axon. [ + ]
Science Academy elects 16 new members
Sixteen of Australia's leading scientists have been honored by election to the Australian Academy of Science.
[ + ]Melbourne Uni report positive on GM canola varieties
A new report from the University of Melbourne has found that genetically modified (GM), herbicide-tolerant canola varieties could be worth up to $AUD135 million a year to Australia's canola and wheat industries. [ + ]
US firm claims Vision Bio infringed patents
A legal battle has erupted over Vision BioSystems' new cancer detection instruments, with US company Ventana Medical Systems filing claims alleging patent infringement in a US court last week. [ + ]
WA centre gets new SNP detection equipment
In a major boost for the WA State Agricultural Biotechnology Centre (SABC) at Murdoch University, researchers will take delivery of a new Transgenomic WAVE Denaturing High Performance Liquid Chromatograph (DHPLC). [ + ]
Computer aided drug discovery
CSIRO scientists have developed a powerful software modelling tool, MolSAR, which has the potential to reduce drug development costs by up to $50 million per drug.
[ + ]Antisense defended in wake of Isis trial failure
Mark Diamond, the CEO of Australian company Antisense Therapeutics, has defended antisense technology in the wake of a failed trial of the technology by US companies Isis Pharmaceuticals and Eli Lilly. [ + ]
Big names scheduled to speak at NSW careers night
AusBiotech's NSW branch has assembled a high-profile line-up for a careers night this Wednesday March 26. [ + ]
Water calculations throw light on greenhouse effect
Scientists have calculated exactly how water behaves - how the water molecule moves and what its precise geometry is - on a microscopic scale and more accurately than ever before.
[ + ]CEO Shaw to leave Ambri
Dr Joe Shaw, the managing director and CEO of Sydney-based biosensor specialist Ambri (ASX: ABI), has resigned from the company and will return to the US. [ + ]
Prana teams with NSV, Schering
Melbourne company Prana Biotechnology has announced an agreement with Neurosciences Victoria and German pharma Schering worth up to $AUD7.5 million over the next three to five years. [ + ]
Queensland collaboration to lead world-first spinal research
Accurately predicting the outcomes of spinal surgery is the aim of a $750,000 joint research venture headed by QUT and the Mater Hospital.
[ + ]Queensland collaboration to lead world-first spinal research
Accurately predicting the outcomes of spinal surgery is the aim of a $750,000 joint research venture headed by QUT and the Mater Hospital.
[ + ]$10m centre seeks diabetes vaccine
The search for a vaccine against juvenile Type-1 diabetes has received a boost with the establishment of a vaccine development centre at the University of Melbourne.
[ + ]
